1Global Strategy for Diagnosis, Management, and Prevention of COPD ( Updated 2011 ).
2Shapiro SD. End-stage chronic obstructive pulmonary disease: the cigarette is burned out but inflammation rages on[ J]. Am J Respir Crit Care Med, 2001,164:339 - 40.
3Cosio MG. Autoimmunity, T-cells and STAT-4 in the pathogenesis of chronic obstructive pulmonary disease[ J ]. Eur Respir J, 2004, 24:3 - 5.
4Cosio MG,Saetta M,Agusti A. Immunologic aspects of chronic ob- structive pulmonary disease[J]. N Engl J Meal,2009, 360(23) : 2445 - 54.
5Brusselle GG,Joos GF,Bracke KR. New insights into the immunol- ogy of chronic obstructive pulmonary disease [ J ]. Lancet, 2011, 10, 378 (9795):1015 -26.
6Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease[ J]. Nat Rev Immunol, 2006,6:823 - 35.
7Demedts IK, Bracke KR, Van Pottelberge G, et al. Accumulation of dendritic ceils and increased CCL20 levels in the airways of pa- tients with chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2007, 175 : 998 - 1005.
8Bratke K, Klug M, Bier A, et al. Function-associated surface mol- ecules on airway dendritic cells in cigarette smokers[ J]. Am J Re- spir Cell Mol Biol, 2008,38 : 655 -60.
9Freeman CM, Curtis JL, Chensue SW. CC chemokine receptor 5 and CXC chemokine receptor 6 expression by lung CDs+ ceils corre- lates with chronic obstructive pulmonary disease severity[ J. Am J Pathal, 2007,171:767 - 76.
10Chrysofakis G, Tzanakis N, Kyriakoy D, et al. Perforin expression and cytotoxic activity of sputum CDs+ lymphocytes in patients with COPD[J]. Chest, 2004,125:71 -6.
